Reasons why independant and credible data makes a HUGE difference:
1) Media exposure which brings new investors to the table which in turn allows us to pay for more research by financing for more money at less dilution.
2) Major medical journal exposure which starts creating "buzz" in the industry...this buzz is what will eventually fuel the demand for BOCX's products. Journal exposure also brings lucrative collaborations
3) More partnerships with premiere institutions like Mayo, UT Anderson, Cedar-Sinai, and Clevelend Clinic -- these are institutions that can bring a lot of $$ and expertise to the table...a lot more than Goshen no offense!!!
4) More industry partnerships
5) Access to capital...sorely needed around here. With access to capital we could trade on a real exchange just for meeting the capital requirements. We could also hire more talent and move EVERYTHING along much faster.
----
Those of you who say these things don't matter are simply
kidding yourself. I love this stock and am standing by it because of what they were accomplish with Abbott, but that shouldn't prevent critical analysis. Independant, credible data is an absolute necessity. Abbott will eventually get around to it (obviously), but the company has no excuse for not producing some legitimate data in the meantime given the cost versus benefit of doing so.
News 
Market Data 
Discover 
